imatinib mesylate has been researched along with Dysembryoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahmoush, L; Guseva, NV; Ma, D; Robinson, RA | 1 |
1 review(s) available for imatinib mesylate and Dysembryoma
Article | Year |
---|---|
Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; DNA Mutational Analysis; Female; Germ-Line Mutation; Humans; Imatinib Mesylate; Middle Aged; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins c-kit; Struma Ovarii; Teratoma; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |